Thomas van Es

IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice.

T. V. van Berkel, J. Kuiper, I. Michon, 2011, Vaccine.

A vaccine against atherosclerosis: myth or reality?

T. V. van Berkel, J. Kuiper, G. V. van Puijvelde, 2008, Future cardiology.

CXCR3 Antagonist NBI-74330 Attenuates Atherosclerotic Plaque Formation in LDL Receptor–Deficient Mice

Johan Kuiper, Helen L Birch, T. V. van Berkel, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Intradermal Delivery of TLR Agonists in a Human Explant Skin Model: Preferential Activation of Migratory Dendritic Cells by Polyribosinic-Polyribocytidylic Acid and Peptidoglycans

S. H. van der Burg, T. D. de Gruijl, Y. van Kooyk, 2013, The Journal of Immunology.

Enactive-Dynamic Social Cognition and Active Inference

Inês Hipólito, T. van Es, Thomas van Es, 2022, Frontiers in Psychology.

Immunomodulation of the inflammatory response in atherosclerosis

J. Kuiper, G. V. van Puijvelde, T. van Es, 2007, Current opinion in lipidology.

A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine.

W. Hennink, W. Jiskoot, E. Mastrobattista, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.